Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Joachim Gerß"'
Autor:
Sonja Ständer, Caroline Forner, Martin Kaatz, Matthias Borowski, Joachim Gerss, Claudia Zeidler, Ulrike Raap, Petra Staubach, Martin Metz, Athanasios Tsianakas, Claudia Riepe, Thomas A. Luger, Marc Urban
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 4, Pp 379-385 (2019)
The aim of this multicentre, randomized, double-blind, placebo-controlled, cross-over, phase-II study was to determine the antipruritic effect of aprepitant vs. placebo in 58 patients with anti-histamine-refractory chronic pruritus in chronic nodular
Autor:
Carmelo Rizzari, Georg Hempel, Joachim Gerß, Martin Schrappe, Anja Möricke, Jan Stary, Petr Smisek, Martin Zimmermann, Massimo Zucchetti, Christian Siebel, Claudia Lanvers-Kaminsky, Joachim Boos, Gudrun Würthwein, Sebastian G. Wicha
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics
Background and Objectives The pharmacokinetics of polyethylene glycol-conjugated asparaginase (PEG-ASNase) are characterized by an increase in elimination over time, a marked increase in ASNase activity levels from induction to reinduction, and high
Autor:
Massimo Zucchetti, Arend von Stackelberg, Georg Hempel, Manfred Fobker, Martin Zimmermann, Christa E. Nath, Jana Golitsch, Martin Schrappe, Joachim Gerss, Carmelo Rizzari, Petr Smisek, Andishe Attarbaschi, Anja Möricke, Claudia Lanvers-Kaminsky, Alaeddin Khalil, Joachim Boos, Gudrun Würthwein, Valentino Conter, Nicola Gökbuget
Publikováno v:
Haematologica
Antibodies against polyethylene glycol (PEG) in healthy subjects raise concerns about the efficacy of pegylated drugs. We evaluated the prevalence of antibodies against PEG among patients with acute lymphoblastic leukemia (ALL) prior to and/or immedi
Publikováno v:
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 60(1)
Autor:
Joachim Gerss, Anja Möricke, Martin Zimmermann, Jan Stary, Carmelo Rizzari, Petr Smisek, Gudrun Würthwein, Claudia Lanvers-Kaminsky, Joachim Boos, Andishe Attarbaschi, Christa E. Nath, Martin Schrappe, Massimo Zucchetti
Publikováno v:
Therapeutic drug monitoring. 42(3)
Background Therapeutic drug monitoring (TDM) can identify patients with subtherapeutic asparaginase (ASNase) activity [silent inactivation (SI)] and prospectively guide therapeutic adaptation. However, limited intra-individual variability is a precon
Autor:
Joachim Gerss, L Makowski, Eva Freisinger, Helmut Baumgartner, J Koeppe, Leo Bronstein, Holger Reinecke, G P Diller
Publikováno v:
European Heart Journal. 40
Background The life-span of patients with congenital heart disease strongly increased during the last decades due to advances in diagnostic and therapeutic approaches. Some cardiac malformations may involve an increased risk of thrombo-embolic compli
Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis
Autor:
Nasser M. Malyar, Eva Freisinger, Dennis Goerlich, Ursula Marschall, Joachim Gerss, Andreas Faldum, J Koeppe, Holger Reinecke
Publikováno v:
European heart journal. 41(38)
Aims Drug-eluting devices (DED) represent a well-established therapy being widely used for endovascular revascularization (EVR) of peripheral vessels. Recent data indicate a two-fold increased long-term mortality in patients treated with paclitaxel-b
Autor:
Arend von Stackelberg, Rosanna Parasole, Martin Zimmermann, Jan Stary, Maria Grazia Valsecchi, Valentino Conter, Luciana Vinti, Anja Moericke, Cristina Matteo, Elena Barisone, Andishe Attarbaschi, David C. Kasper, Daniela Silvestri, Sabine Legien, Andrea Ballerini, Martin Schrappe, Joachim Gerss, Antonella Colombini, Carmelo Rizzari, Bettina Reismüller, Christin Linderkamp, Concetta Micalizzi, Joachim Boos, Gudrun Wuerthwein, Massimo Zucchetti, Andrea Biondi, Petr Smisek, Michael C. Frühwald, Claudia Lanvers-Kaminsky
Publikováno v:
Haematologica
Asparagine levels in cerebrospinal fluid and serum asparaginase activity were monitored in children with acute lymphoblastic leukemia treated with pegylated-asparaginase. The drug was given intravenously at a dose of 2,500 IU/m2 on days 12 and 26. Se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c565d08aa6dfc3246c6e4b015f2902b0
http://hdl.handle.net/10281/226174
http://hdl.handle.net/10281/226174
Autor:
Martin Zimmermann, Martin Schrappe, Andrea Rüffer, Christa E. Nath, Samiuela Lee, Massimo Zucchetti, Joachim Boos, Carmelo Rizzari, Joachim Gerss, Sara Elitzur, Claudia Lanvers-Kaminsky, Petr Smisek, Gudrun Würthwein, Anja Möricke, Andrea Ballerini, Andishe Attarbaschi
Background: In the international AIEOP-BFM ALL 2009 trial, asparaginase (ASE) activity was monitored after each dose of pegylated Escherichia coli ASE (PEG-ASE). Two methods were used: the aspartic acid β-hydroxamate (AHA) test and medac asparaginas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3bbb58b56df847a8834963e6f06e2da
http://hdl.handle.net/10281/336927
http://hdl.handle.net/10281/336927
Autor:
Christoph Schmidt, Hugo Van Aken, Carola Wempe, Melanie Meersch, Alexander Zarbock, Andreas Hoffmeier, Joachim Gerss
Publikováno v:
Intensive care medicine. 43(11)
Care bundles are recommended in patients at high risk for acute kidney injury (AKI), although they have not been proven to improve outcomes. We sought to establish the efficacy of an implementation of the Kidney Disease Improving Global Outcomes (KDI